tesamorelin e ipamorelin + (10/3 MG) Tesamorelin & Ipamorelin - Injectable

British Journal of Nutrition, 132 (8), 11101122

Epibiotech In December 2022, Epibiotech applied to the Korean Ministry of Food and Safety for an IND to begin a phase 1 trial for its cell therapy EPI-001

This leads to the indirect activation of v-raf murine sarcoma viral oncogene homolog B1 (RAF) kinases, which can subsequently activate the MAPK effector kinase MEK and finally MAPK, which can then translocate to the nucleus to activate transcription factors responsible for regulating a large number of genes

Moreover, this method has an important advantage because the layer thickness can be controlled by adjusting the growth parameters